Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIM51EP, or tripartite motif-containing 51E, pseudogene, is a predicted or annotated pseudogene in the human genome related to the TRIM51 gene family. TRIM proteins generally are E3 ubiquitin ligases involved in innate immunity, protein degradation, and various cellular processes[4]. However, pseudogenes like TRIM51EP do not encode functional proteins. Recent research shows that some pseudogenes can play coding-independent roles, such as acting as "competitive endogenous RNAs" (ceRNAs) that bind microRNAs and regulate the expression of protein-coding partner genes[1][3]. While well-characterized examples exist (such as PTENP1 for PTEN), no published evidence suggests that TRIM51EP is biologically active or directly involved in human disease. Additional context: - TRIM gene family: This is a large family characterized by the tripartite motif (RING, B-box, and coiled-coil domains) and typically involved in ubiquitination and regulatory roles in immune response and cancer[4]. - Pseudogenes: While most pseudogenes are considered non-functional, a subset can regulate gene expression by titrating away microRNAs, thus influencing the levels of their protein-coding homologs[1][3]. These actions, when present, are gene-specific and not universal for all pseudogenes. Summary judgment: - TRIM51EP is a pseudogene and not a valid therapeutic target. - There is nothing to suggest it is druggable, a receptor, or interpretable as a conventional drug target. - Listing it as a target is incorrect under most modern pharmaceutical and biomarker discovery standards.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing 51E, pseudogene (TRIM51EP).